Nicholas Investment Partners’s Gilead Sciences GILD Stock Holding History

Nicholas Investment Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-12,733	Closed	-$1.17M	–	307
2016 Q1	$1.17M	Sell	12,733 -6,923	-35%	-$624K	0.09%	278
2015 Q4	$1.99M	Buy	19,656 +4,920	+33%	+$512K	0.14%	255
2015 Q3	$1.45M	Buy	14,736 +6,516	+79%	+$724K	0.1%	270
2015 Q2	$962K	Hold	8,220	–	–	0.06%	288
2015 Q1	$807K	Sell	8,220 -8,899	-52%	-$904K	0.05%	295
2014 Q4	$1.61M	Hold	17,119	–	–	0.1%	264
2014 Q3	$1.82M	Buy	17,119 +2,335	+16%	+$229K	0.11%	252
2014 Q2	$1.23M	Hold	14,784	–	–	0.07%	261
2014 Q1	$1.05M	Sell	14,784 -8,263	-36%	-$648K	0.09%	273
2013 Q4	$1.73M	Hold	23,047	–	–	0.13%	241
2013 Q3	$1.45M	Buy	+23,047	New	+$1.38M	0.12%	252

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nicholas Investment Partners's GILD Position: Q2 2016 in Review

Nicholas Investment Partners sold out of Gilead Sciences (GILD) in Q2 2016, closing a stake of 12,733 shares — an estimated $1.17M sold.

Nicholas Investment Partners first reported a position in GILD in Q3 2013 and held it in 11 quarters. The position peaked at $1.99M in Q4 2015. 1,596 funds tracked by Wall St. Rank hold GILD as of Q2 2016.

Nicholas Investment Partners reported no remaining Gilead Sciences position as of Q2 2016 after selling out during the quarter.
Nicholas Investment Partners sold 12,733 Gilead Sciences shares in Q2 2016, an estimated $1.17M.
Nicholas Investment Partners first reported a position in Gilead Sciences in Q3 2013 and held it in 11 quarters.
Nicholas Investment Partners's Gilead Sciences position peaked at $1.99M in Q4 2015.
1,596 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2016.

Based on Nicholas Investment Partners's 13F filing for Q2 2016, filed 12 Aug 2016.